Abramson Cancer Center at the University of Pennsylvania
Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma | Colorectal Adenocarcinoma Metastatic in the Liver | Recruiting | Phase 2 | 2026-10-05 | NCT07082439 | |
| Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) | cancer, neoplasm | Recruiting | Not applicable | 2026-06-12 | NCT07454499 | |
| Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma | esophageal adenocarcinoma, gastric adenocarcinoma, gastroesophageal junction adenocarcinoma | Not yet recruiting | Phase 2 | 2026-06-05 | NCT07059611 | |
| Telehealth Collaborative Care Model (CoCM) in Lung Cancer | Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, anxiety, anxiety disorder, depressive disorder, disease, lung disorder, lung neoplasm, neoplasm, psychiatric disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-05-28 | NCT07102147 | |
| Epcoritamab-CAR T Cells for Large B-cell Lymphomas | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-05-27 | NCT06458439 | |
| Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) | cancer, neoplasm | Recruiting | Not stated | 2026-03-13 | NCT07471958 | |
| eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer | cancer, neoplasm | Recruiting | Not applicable | 2026-01-16 | NCT05427240 | |
| Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, disease susceptibility, inherited disease susceptibility, neoplasm | Active, not recruiting | Not applicable | 2025-02-10 | NCT04774445 |